SCHEMBL8934636

SCHEMBL8934636

Nc1ccc(-c2c(O)c3ccccc3oc2=O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.68
KDM4E B2RXH2 2/20 0.53
NQO1 P15559 6/20 0.51
ALDH1A1 P00352 2/20 0.51
MAPK1 P28482 2/20 0.51
KMT2A Q03164 2/20 0.51
CYP2C9 P11712 2/20 0.51
MEN1 O00255 1/20 0.51
ABCB11 O95342 1/20 0.51
LMNA P02545 1/20 0.51
TP53 P04637 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
TSHR P16473 1/20 0.51
CYP2C19 P33261 1/20 0.51
PDE4D Q08499 1/20 0.51
PCSK7 Q16549 1/20 0.51
GPR35 Q9HC97 1/20 0.51
CA12 O43570 1/20 0.49
CA9 Q16790 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL669375 0.87 MAOB (0.70) MAOBKDM4ENQO1ALDH1A1MAPK1
SCHEMBL29466790 0.87 MAOB (0.70) MAOBKDM4ENQO1ALDH1A1MAPK1
SCHEMBL27790298 0.84 MAOB (0.72) MAOBKDM4ENQO1ALDH1A1MAPK1
SCHEMBL11480850 0.84 MAOB (0.68) MAOBKDM4ENQO1ALDH1A1MAPK1
SCHEMBL11480111 0.84 MAOB (0.68) MAOBKDM4ENQO1ALDH1A1MAPK1
SCHEMBL11485562 0.81 MAOB (1.00) MAOBKDM4ENQO1ALDH1A1KMT2A
SCHEMBL9210163 0.81 MAOB (0.63) MAOBKDM4ENQO1ALDH1A1MAPK1
Xylocoumarol SCHEMBL2111715 0.80 MAOB (0.62) MAOBKDM4ENQO1ALDH1A1MAPK1
SCHEMBL11489232 0.78 MAOB (0.73) MAOBKDM4ENQO1ALDH1A1MAPK1
SCHEMBL11693383 0.76 GAA (0.69) KDM4ENQO1ALDH1A1MAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO claimed
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO disclosed